Treatment of weight regain in obese patients after bariatric surgery

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Obesity is a common pathology associated with carbohydrate metabolism disorders and increased cardiovascular risk. Bariatric surgery is recognized as the most effective treatment for morbid obesity, leading to significant weight loss and improved glycemic control and comorbid conditions. Despite the relatively high effectiveness of bariatric surgery compared to traditional methods of treating obesity, there are cases of both ineffective weight loss and weight regain. Due to the relatively recent introduction of bariatric surgery into medical practice, prospective long-term follow-up of patients is scarce and often contradictory. Experience in the treatment of repeated weight gain after bariatric interventions is limited and is represented mainly by surgical methods for correcting previously performed modifications of the gastrointestinal tract. The purpose of this review is to systematize the available data on the conservative treatment of weight gain: features of dietary counseling, selection of a physical activity regimen, as well as experience in the use of a number of medications.

Full Text

Restricted Access

About the authors

Galina V. Semikova

Pavlov University

Author for correspondence.
Email: Semikovagv@yandex.ru
ORCID iD: 0000-0003-0791-4705
SPIN-code: 4534-0974

Cand. Sci. (Med.), Teaching Assistant at the Department of Faculty Therapy with a Course of Endocrinology, Cardiology with the Clinic n.a. Academician G.F. Lang

Russian Federation, St. Petersburg

A. R. Volkova

Pavlov University

Email: Semikovagv@yandex.ru
ORCID iD: 0000-0002-5189-9365
SPIN-code: 4007-1288
Russian Federation, St. Petersburg

Y. S. Khalimov

Pavlov University

Email: Semikovagv@yandex.ru
ORCID iD: 0000-0002-7755-7275
SPIN-code: 7315-6746
Russian Federation, St. Petersburg

A. V. Ergert

Pavlov University

Email: Semikovagv@yandex.ru
Russian Federation, St. Petersburg

E. A. Timoschenko

Pavlov University

Email: Semikovagv@yandex.ru
Russian Federation, St. Petersburg

References

  1. Voorwinde V., Steenhuis I.H.M., Janssen I.M.C., et al. Definitions of long-term weight regain and their associations with clinical outcomes. Obes Surg. 2020;30(2):527–36.
  2. Shukla A.P., He D. Current concepts in management of weight regain following bariatric surgery. Expert Rev Endocrinol Metab. 2018;13(2):67–76. doi: 10.1080/17446651.2018.1447922.
  3. Courcoulas A.P., King W.C., Belle S.H., et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA. Surg. 2018;153(5):427–34. doi: 10.1001/jamasurg.2017.5025.
  4. Keeney B.J., Fulton-Kehoe D., Wickizer T.M., et al. Clinically significant weight gain 1 year after occupational back injury. J Occup Environ Med. 2013;55(3):318–24.
  5. Apovian C.M., Aronne L.J., Bessesen D.H., et al. Endocrine Society. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.
  6. Hansen D., Decroix L., Devos Y., et al. Towards optimized care after bariatric surgery by physical activity and exercise intervention: a review. Obes Surg. 2020;30(3):1118–25.
  7. King W.C., Chen J.Y., Bond D.S., et al. Objective assessment of changes in physical activity and sedentary behavior: prethrough 3 years post-bariatric surgery. Obes. (Silver Spring). 2015;23(6):1143–50.
  8. Paul L., van der Heiden C., Hoek H.W. Cognitive behavioral therapy and predictors of weight loss in bariatric surgery patients. Curr. Opin. Psychiatry. 2017;30(6):474–79.
  9. Mechanick J.I., Apovian C., Brethauer S., et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists – executive summary. Endocr Pract. 2019;25(12): 1346–59.
  10. Zalesin K.C., Franklin B.A., Miller W.M., et al. Preventing weight regain after bariatric surgery: an overview of lifestyle and psychosocial modulators. Am. J. Lifestyle Med. 2010;4(2):113–20.
  11. Carnero E.A., Dubis G.S., Hames K.C., et al. Randomized trial reveals that physical activity and energy expenditure are associated with weight and body composition after RYGB. Obes (Silver Spring). 2017;25(7):1206–16.
  12. Leahy C.R., Luning A. Review of nutritional guidelines for patients undergoing bariatric surgery. AORN. J. 2015;102(2):153–60
  13. Pizato N., Botelho P.B., Gonçalves V.S.S., et al. Effect of Grazing Behavior on Weight Regain Post-Bariatric Surgery: A Systematic Review. Nutrients. 2017;9(12):1322. doi: 10.3390/nu9121322.
  14. Magro D.O., Geloneze B., Delfini R., et al. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008; 18(6):648–51.
  15. Rosenberger P.H., Henderson K.E., White M.A., et al. Physical activity in gastric bypass patients: associations with weight loss and psychosocial functioning at 12-month follow-up. Obes Surg. 2011;21:1564–69.
  16. King W.C., Hsu J.Y., Belle S.H., et al. Pre- to postoperative changes in physical activity: report from the longitudinal assessment of bariatric surgery-2 (LABS-2). Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2012;8:522–32.
  17. Chaston T.B., Dixon J.B., O’Brien P.E. Changes in fat-free mass during significant weight loss: a systematic review. Int J Obes (Lond). 2007;31(5):743–50.
  18. Istfan N.W., Lipartia M., Anderson W.A., et al. Approach to the Patient: Management of the Post-Bariatric Surgery Patient With Weight Regain. J Clin Endocrinol Metab. 2021;106(1):251–63. doi: 10.1210/clinem/dgaa702.
  19. Stanford F.C., Alfaris N., Gomez G., et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study. Surg. Obes. Relat. Dis. 2017;13(3):491-500.
  20. Boger BS, Queiroz NL, Noriega PEP, et al. Treatment with Antiobesity Drugs in Weight Regain After Bariatric Surgery: a Retrospective Cohort Study. Obes Surg. 2023;33(9):2941–44. doi: 10.1007/s11695-023-06736-7
  21. Zoss I., Piec G., Horber F.F. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish adjustable gastric band. Obes Surg. 2002;12(1):113–17. doi: 10.1381/096089202321144685.
  22. Dharmaratnam V.M., Lim E., Eng A., et al. Revisional Surgery or Pharmacotherapy for Insufficient Weight Loss and Weight Regain After Primary Bariatric Procedure: a Descriptive Study. Obes Surg. 2022;32(10):3298–304. doi: 10.1007/s11695-022-06191-w.
  23. Miras A.D., Pérez-Pevida B., Aldhwayan M., et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diab Endocrinol. 2019;7(7):549–59. doi: 10.1016/S2213-8587(19)30157-3.
  24. Wharton S., Kuk J.L., Luszczynski M., et al. Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post-bariatric surgery [published correction appears in Clin. Obes. 2019;9(6):e12338]. Clin Obes. 2019;9(4):e12323. Doi:.10.1111/cob.12323.
  25. Suliman M., Buckley A., Al Tikriti A., et al. Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients. Diab Obes Metab. 2019;21(6):1498–501. doi: 10.1111/dom.13672.
  26. Horber F.F., Steffen R. Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study [published correction appears in Obes Surg. 2021;31(7):3386]. Obes Surg. 2021;31(1):93–100. doi: 10.1007/s11695-020-04856-y.
  27. Lautenbach A., Wernecke M, Huber T.B., et al. The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis. Obes Surg. 2022;32(10):3280–88. doi: 10.1007/s11695-022-06211-9.
  28. Jensen A.B., Renström F., Aczél S., et al. Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. Obes Surg. 2023;33(4):1017–25. doi: 10.1007/s11695-023-06484-8.
  29. ClinicalTrials.gov. Semaglutide 2.4 mg in patients with poor weight-loss (BARI-STEP). Betheseda (MD: National Library of Medicine (US. Available at: https://clinicaltrials.gov/ct2/show/NCT05073835 NCT05073835).
  30. Jastreboff A.M., Aronne L.J., Ahmad N.N., et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205–16. doi: 10.1056/NEJMoa2206038.
  31. Kashyap S.R., Kheniser K., Aminian A, et al. Double-blinded, randomized, and controlled study on the effects of canagliflozin after bariatric surgery: A pilot study. Obes Sci Pract. 2020;6(3):255–63. doi: 10.1002/osp4.409.
  32. Toth A.T., Gomez G., Shukla A.P., et al. Weight loss medications in young adults after bariatric surgery for weight regain or inadequate weight loss: a multi-center study. Child Basel Switz. 2018;5.
  33. Treviño R.P., Piña Ch., Fuentes J.C., et al. Evaluation of Medicare’s Intensive Behavioral Therapy for Obesity: The BieneStar Experience. Am J Prev Med. 2018;54(4):497–502. doi: 10.1016/j.amepre.2018.01.018.
  34. Wadden T., Tsai A., Tronieri J. A Protocol to Deliver Intensive Behavioral Therapy (IBT) for Obesity in Primary Care Settings: The MODEL-IBT Program. Obesity (Silver Spring). 2019;27(10):1562–66. doi: 10.1002/oby.22594.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. The effectiveness of various GLP-1 receptor agonists in the treatment of PMT after BO in a study by A.V. Jensen et al. (adapted from A.V. Jensen et al., 2023) [28]

Download (283KB)
Indexing metadata

Copyright (c) 2024 Bionika Media